Role of the QuantiFERON-TB gold in tube in ruling out tuberculosis in end stage renal disease patients receiving hemodialysis

Background: It is difficult to diagnose tuberculosis (TB) in dialysis patients because of the high rate of extrapulmonary TB in these patients compared with the general population. Recently, a new diagnostic test called QuantiFERON(QFT) has been developed and shown promise as a diagnostic tool for a...

Full description

Bibliographic Details
Main Authors: Khaled H. Mohamed, Manal M. Hashem, Samar M. Sharaf
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2012-07-01
Series:Egyptian Journal of Chest Disease and Tuberculosis
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0422763812000088
id doaj-78a15b01c5a64ca8ba3bfbd0170af59a
record_format Article
spelling doaj-78a15b01c5a64ca8ba3bfbd0170af59a2020-11-24T21:12:50ZengWolters Kluwer Medknow PublicationsEgyptian Journal of Chest Disease and Tuberculosis0422-76382012-07-0161313513810.1016/j.ejcdt.2012.10.007Role of the QuantiFERON-TB gold in tube in ruling out tuberculosis in end stage renal disease patients receiving hemodialysisKhaled H. Mohamed0Manal M. Hashem1Samar M. Sharaf2Department of Chest Diseases, Faculty of Medicine, Zagazig University, Zagazig, Sharqia, EgyptDepartment of Internal Medicine, Faculty of Medicine, Zagazig University, Zagazig, Sharqia, EgyptDepartment of Clinical Pathology, Faculty of Medicine, Zagazig University, Zagazig, Sharqia, EgyptBackground: It is difficult to diagnose tuberculosis (TB) in dialysis patients because of the high rate of extrapulmonary TB in these patients compared with the general population. Recently, a new diagnostic test called QuantiFERON(QFT) has been developed and shown promise as a diagnostic tool for active TB diseases and latent TB infection. The aim of the present study was to analyze the performance of QuantiFERON-TB Gold in tube (QFT-G) in end stage renal disease patients receiving hemodialysis. Methods: QuantiFERON Gold in tube (QFT-GIT) were prospectively performed in 50 end stage renal disease (ESRD) cases undergoing hemodialysis (HD), including 6 patients with active TB and evaluated the utility of this test in dialysis patients. Results: Among 50 dialysis patients, positive QFT results occurred in 10 (20%), negative QFT results occurred in 25 (50%) and indeterminate QFT results occurred in 15 (30%). All six active TB patients had positive QFT results, and none of the 25 patients with negative results had active TB. Among 7 patients with a history of active TB, 2 (28.5%) had positive results. Although the indeterminate rate was relatively high, no patient with an indeterminate result had active TB. Among 30 cases after excluding the patients with previous TB and indeterminate results, the sensitivity of the QFT is 100% (6 of 6) and the specificity is 91.6% (22 of 24 cases). Conclusions: Our data suggest that the QFT test is a useful supplementary tool for the diagnosis of active TB even in dialysis patients. Negative and indeterminate results on this test may be used to exclude the presence of active TB.http://www.sciencedirect.com/science/article/pii/S0422763812000088DiagnosisDialysisExtrapulmonary TBQuantiFERONTuberculosis
collection DOAJ
language English
format Article
sources DOAJ
author Khaled H. Mohamed
Manal M. Hashem
Samar M. Sharaf
spellingShingle Khaled H. Mohamed
Manal M. Hashem
Samar M. Sharaf
Role of the QuantiFERON-TB gold in tube in ruling out tuberculosis in end stage renal disease patients receiving hemodialysis
Egyptian Journal of Chest Disease and Tuberculosis
Diagnosis
Dialysis
Extrapulmonary TB
QuantiFERON
Tuberculosis
author_facet Khaled H. Mohamed
Manal M. Hashem
Samar M. Sharaf
author_sort Khaled H. Mohamed
title Role of the QuantiFERON-TB gold in tube in ruling out tuberculosis in end stage renal disease patients receiving hemodialysis
title_short Role of the QuantiFERON-TB gold in tube in ruling out tuberculosis in end stage renal disease patients receiving hemodialysis
title_full Role of the QuantiFERON-TB gold in tube in ruling out tuberculosis in end stage renal disease patients receiving hemodialysis
title_fullStr Role of the QuantiFERON-TB gold in tube in ruling out tuberculosis in end stage renal disease patients receiving hemodialysis
title_full_unstemmed Role of the QuantiFERON-TB gold in tube in ruling out tuberculosis in end stage renal disease patients receiving hemodialysis
title_sort role of the quantiferon-tb gold in tube in ruling out tuberculosis in end stage renal disease patients receiving hemodialysis
publisher Wolters Kluwer Medknow Publications
series Egyptian Journal of Chest Disease and Tuberculosis
issn 0422-7638
publishDate 2012-07-01
description Background: It is difficult to diagnose tuberculosis (TB) in dialysis patients because of the high rate of extrapulmonary TB in these patients compared with the general population. Recently, a new diagnostic test called QuantiFERON(QFT) has been developed and shown promise as a diagnostic tool for active TB diseases and latent TB infection. The aim of the present study was to analyze the performance of QuantiFERON-TB Gold in tube (QFT-G) in end stage renal disease patients receiving hemodialysis. Methods: QuantiFERON Gold in tube (QFT-GIT) were prospectively performed in 50 end stage renal disease (ESRD) cases undergoing hemodialysis (HD), including 6 patients with active TB and evaluated the utility of this test in dialysis patients. Results: Among 50 dialysis patients, positive QFT results occurred in 10 (20%), negative QFT results occurred in 25 (50%) and indeterminate QFT results occurred in 15 (30%). All six active TB patients had positive QFT results, and none of the 25 patients with negative results had active TB. Among 7 patients with a history of active TB, 2 (28.5%) had positive results. Although the indeterminate rate was relatively high, no patient with an indeterminate result had active TB. Among 30 cases after excluding the patients with previous TB and indeterminate results, the sensitivity of the QFT is 100% (6 of 6) and the specificity is 91.6% (22 of 24 cases). Conclusions: Our data suggest that the QFT test is a useful supplementary tool for the diagnosis of active TB even in dialysis patients. Negative and indeterminate results on this test may be used to exclude the presence of active TB.
topic Diagnosis
Dialysis
Extrapulmonary TB
QuantiFERON
Tuberculosis
url http://www.sciencedirect.com/science/article/pii/S0422763812000088
work_keys_str_mv AT khaledhmohamed roleofthequantiferontbgoldintubeinrulingouttuberculosisinendstagerenaldiseasepatientsreceivinghemodialysis
AT manalmhashem roleofthequantiferontbgoldintubeinrulingouttuberculosisinendstagerenaldiseasepatientsreceivinghemodialysis
AT samarmsharaf roleofthequantiferontbgoldintubeinrulingouttuberculosisinendstagerenaldiseasepatientsreceivinghemodialysis
_version_ 1716749790331535360